Alternatives to<i>in vivo</i>tests to detect endocrine disrupting chemicals (EDCs) in fish and amphibians – screening for estrogen, androgen and thyroid hormone disruption
Stefan Scholz(Helmholtz Centre for Environmental Research), Michelle R. Embry(Health and Environmental Sciences Institute), Scott E. Belanger(Procter & Gamble (United States)), Daniel L. Villeneuve(Environmental Protection Agency), R. Davì(ExxonMobil (United States)), Jeffrey S. Denny(Environmental Protection Agency), François Busquet(Johns Hopkins University), Marc Léonard(L'Oréal (France)), Barbara Demeneix(Muséum national d'Histoire naturelle), Patrick Renner(Helmholtz Centre for Environmental Research), Mark E. McMaster(Environment and Climate Change Canada)
Cited by 65
Related Papers
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
|Proceedings of the National Academy of Sciences|1995|6.2k
Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment
|Environmental Toxicology and Chemistry|2009|2.6k
Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?
|Environmental Health Perspectives|2012|1.3k
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
|Toxicological Sciences|2014|725